FibroGen Inc. (FGEN)
undefined
undefined%
At close: undefined
0.62
0.76%
Pre-market Jan 08, 2025, 04:25 AM EST

FibroGen Inc. Revenue Breakdown

Quarter Sep 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Sep 30, 2019
Drug Product Revenue Revenue -262.00K 24.49M 1.05M 1.32M 14.27M 2.11M 6.48M 1.09M 7.59M 1.13M 13.44M -8.65M 8.48M 35.92M 686.00K 8.24M 5.37M 579.00K
Drug Product Revenue Revenue Growth -101.07% +2227.57% -20.30% -90.75% +576.72% -67.43% +492.50% -85.61% +572.04% -91.59% -255.43% -201.98% -76.39% +5136.44% -91.67% +53.35% +827.81% n/a
Product Revenue 46.21M 30.54M n/a 29.39M n/a n/a n/a n/a n/a n/a n/a 13.37M n/a n/a 27.90M 19.83M n/a n/a
Product Revenue Growth +51.32% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a +40.67% n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
China Revenue 109.38M 84.63M 55.64M 72.50M 132.40M 112.92M 16.89M 25.78M
China Revenue Growth +29.24% +52.10% -23.25% -45.24% +17.26% +568.74% -34.50% n/a
Europe Revenue 9.55M 33.82M 131.24M 67.16M n/a n/a n/a n/a
Europe Revenue Growth -71.77% -74.23% +95.42% n/a n/a n/a n/a n/a
Japan Revenue 15.87M 9.76M 2.31M 36.66M n/a n/a n/a n/a
Japan Revenue Growth +62.51% +323.60% -93.71% n/a n/a n/a n/a n/a
United States Revenue 12.96M 12.52M 46.12M n/a n/a n/a n/a n/a
United States Revenue Growth +3.53% -72.86% n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 17.55M 22.28M 22.82M 24.22M 25.57M 31.18M 34.27M 33.97M 29.90M 30.26M 30.56M 34.74M 25.85M 32.55M 30.78M 42.25M -48.98M 63.53M 49.60M 50.71M 35.82M 26.74M 22.21M 17.85M 15.36M 15.05M 15.55M 13.85M 12.95M 13.43M 11.53M 12.59M 11.65M 10.38M 11.42M 12.96M 11.24M 9.68M 10.48M
Selling, General, and Administrative Revenue Growth -21.20% -2.38% -5.79% -5.28% -17.99% -9.03% +0.91% +13.59% -1.18% -1.00% -12.02% +34.37% -20.58% +5.77% -27.15% -186.26% -177.09% +28.09% -2.18% +41.55% +33.97% +20.39% +24.42% +16.25% +2.00% -3.18% +12.27% +6.93% -3.52% +16.44% -8.38% +8.06% +12.24% -9.12% -11.94% +15.38% +16.08% -7.65% n/a
Research and Development Revenue 21.71M 34.11M 38.39M 51.70M 61.19M 95.48M 74.49M 61.63M 75.18M 70.96M 89.02M 113.92M 75.88M 122.57M 74.68M 78.13M 58.48M 61.41M 54.90M 56.80M 49.96M 52.01M 50.50M 70.28M 56.44M 52.14M 56.97M 52.47M 50.34M 46.98M 46.73M 50.61M 40.56M 52.39M 43.65M 59.92M 52.07M 51.55M 50.54M
Research and Development Revenue Growth -36.35% -11.16% -25.75% -15.51% -35.91% +28.18% +20.86% -18.03% +5.95% -20.28% -21.86% +50.13% -38.09% +64.13% -4.42% +33.62% -4.78% +11.86% -3.34% +13.68% -3.93% +2.99% -28.15% +24.52% +8.26% -8.49% +8.59% +4.24% +7.14% +0.53% -7.66% +24.78% -22.59% +20.03% -27.16% +15.08% +1.00% +2.01% n/a

Create Price Alert on FGEN

Your price alert will notify you when the stock price is above 0.62.

Add to Watchlist